Timeliness of Surveillance during Outbreak of Shiga Toxin–producing<i>Escherichia coli</i>Infection, Germany, 2011Mathias Altmann, Matthias an der Heiden, Anke Spode et al.|Emerging infectious diseases|2011Cited by 45
Infektionsumfeld von erfassten COVID-19-Ausbrüchen in DeutschlandSilke Buda, Ute Rexroth, Matthias an der Heiden et al.|Robert-Koch-Institut (RKI)|2020Cited by 30
Enhanced surveillance during a large outbreak of bloody diarrhoea and haemolytic uraemic syndrome caused by Shiga toxin/verotoxin-producing Escherichia coli in Germany, May to June 2011Maria Wadl, Tim Eckmanns, Thorsten Rieck et al.|Eurosurveillance|2011Cited by 30
Effectiveness of the AS03-Adjuvanted Vaccine against Pandemic Influenza Virus A/(H1N1) 2009 – A Comparison of Two Methods; Germany, 2009/10Helmut Uphoff, Udo Buchholz, Matthias an der Heiden et al.|PLoS ONE|2011Cited by 13
Evaluation of the German surveillance system for hepatitis B regarding timeliness, data quality, and simplicity, from 2005 to 2014Lena Boes, Ruth Zimmermann, Claudia Houareau et al.|Public Health|2020Cited by 10